InvestorsHub Logo
Followers 466
Posts 26934
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Wednesday, 04/07/2010 9:31:22 AM

Wednesday, April 07, 2010 9:31:22 AM

Post# of 7747
8:30AM CytRx to initiate a Phase 2 clinical trial with bafetinib in advanced prostate cancer (CYTR) 1.12 : Co announces plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.


surf's up......crikey